News

CRISPR-Cas9 and iPSC advances hold treatment promise for schizophrenia, addiction, Zika infection and other diseases. The studies were presented at Neuroscience 2017, the annual meeting of the Society for Neuroscience

Quotient is focused on delivering a portfolio of innovative services encompassing formulation development, clinical trial and commercial manufacturing, and clinical pharmacology.

The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D has announced today that its project to increase knowledge of antibody (Ab) structures has reached its first major milestone – 12 antibody structures have been deposited into the European Bioinformatics Institute’s (EMBL-EBI) Protein Data Bank (PDB).

Researchers have found that attaching a protein called vascular endothelial growth factor to microscopic particles can increase the survival time of stem cells, which could be used to help healing of the tissues, after the injection into the body.

The new findings suggest that the chronic and difficult-to-treat condition, recurrent respiratory papillomatosis, is disappearing in Australian children as a result of the nation’s highly successful HPV vaccination program.

A global study of GBS, bacteria that cause stillbirth and infant death, shows that Africa has the highest incidence. Wits University is pioneering a vaccine.

A Rutgers-led study shows promise and potential peril in reversing hearing loss.

Stem cells taken from muscle tissue could promote better blood flow in patients with diabetes who develop peripheral artery disease, a painful complication that can require surgery or lead to amputation.

A new stem cell study conducted at the University of Copenhagen shows how we may increase the vital production of insulin in patients suffering from diabetes.

Researchers around the world are pursuing a "universal" flu vaccine, one that would protect against most or all seasonal and pandemic strains of the flu virus.